Nvidia-backed AI drug developer Iambic raises $150m in IPO
Iambic said it will use the proceeds to advance three early-stage cancer drug candidates.
We haven't written up this one. Tech in Asia has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.